Dr Reddy's Gets SEC Nod for Higher Semaglutide Dose in Ongoing Phase III Study, Govt Sites Mandated Dr. Divya Colin30 May 2025 8:14 PM ISTNew Delhi: In response to the proposal presented by the Dr Reddy's Laboratories, the Subject Expert Committee (SEC) functional under the Central Drug...
CDSCO Panel Clears Sanofi's Updated Myozyme Insert, Seeks Revision on Administration Guidance Dr. Divya Colin30 May 2025 7:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended the approval of the...
CDSCO Committee Recommends SpinoS to Conduct BE Study with Vitamin D Screening Conditions Dr. Divya Colin30 May 2025 1:00 PM ISTNew Delhi: The SpinoS Lifescience And Research has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Only Licensed Importers Can Overprint Labels Under Rule 104A, Clarifies CDSCO Dr. Divya Colin29 May 2025 8:05 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has clarified that overprinting or stickering of drug products under the Drugs...
Expert Panel Tells IPCA to Revise Hydroxychloroquine Phase III Trial for Diabetes Dr. Divya Colin28 May 2025 11:35 PM ISTNew Delhi: In response to the proposal presented by IPCA Laboratories Limited, the Subject Expert Committee (SEC) functional under the Central Drug...
CDSCO Panel Accepts BE Report, Tells Intas Pharma to Conduct Phase III Trial for Semaglutide Dr. Divya Colin28 May 2025 3:00 PM ISTNew Delhi: In response to a proposal submitted by Intas Pharmaceuticals, the Subject Expert Committee (SEC) under the Central Drugs Standard Control...
Centre Lists 34 Antimicrobials, Antivirals for Proposed Ban in Animals Under Drugs Act Farhat Nasim27 May 2025 7:39 PM ISTNew Delhi: The Central Government has issued a draft notification proposing the prohibition of import, manufacture, sale, and distribution of a total...
CDSCO Panel Clears Abbott's Phase IV Trial for Empagliflozin + Metformin FDC, Seeks More Sites Dr. Divya Colin26 May 2025 8:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to Abbott Healthcare...
Delhi HC Quashes IPO's Patent Rejection of Taiho Pharma's Cancer Drug, Orders Re-evaluation Farhat Nasim25 May 2025 4:00 PM ISTNew Delhi: In a ruling impacting pharmaceutical patent jurisprudence in India, the Delhi High Court has set aside the Indian Patent Office's (IPO)...
CDSCO Panel Approves Fabrazyme Label Update, Asks Sanofi to Submit EMA Nod Dr. Divya Colin25 May 2025 3:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to Sanofi Healthcare...
Macleods Gets CDSCO Panel Go Ahead For Semaglutide Trials, Preclinical Data Sought Farhat Nasim24 May 2025 9:54 PM ISTNew Delhi: The Subject Expert Committee (SEC) on Endocrinology and Metabolism, operating under the Central Drugs Standard Control Organisation...
Sanofi Gets CDSCO Panel Nod to Update Aldurazyme Prescribing Information Dr. Divya Colin24 May 2025 6:55 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to Sanofi Healthcare...
